RNA vs. RXST
Compare and contrast key facts about Avidity Biosciences, Inc. (RNA) and RxSight, Inc. (RXST).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: RNA or RXST.
Correlation
The correlation between RNA and RXST is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
RNA vs. RXST - Performance Comparison
Key characteristics
RNA:
1.90
RXST:
-0.87
RNA:
2.74
RXST:
-1.22
RNA:
1.33
RXST:
0.86
RNA:
2.22
RXST:
-0.79
RNA:
7.04
RXST:
-1.61
RNA:
19.29%
RXST:
26.53%
RNA:
71.51%
RXST:
48.82%
RNA:
-86.45%
RXST:
-53.63%
RNA:
-39.24%
RXST:
-52.20%
Fundamentals
RNA:
$3.81B
RXST:
$1.24B
RNA:
-$2.88
RXST:
-$0.81
RNA:
$7.92M
RXST:
$109.81M
RNA:
$6.60M
RXST:
$70.16M
RNA:
-$256.60M
RXST:
-$18.36M
Returns By Period
In the year-to-date period, RNA achieves a 9.70% return, which is significantly higher than RXST's -10.62% return.
RNA
9.70%
10.30%
-29.14%
128.18%
N/A
N/A
RXST
-10.62%
1.12%
-42.74%
-44.96%
N/A
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
RNA vs. RXST — Risk-Adjusted Performance Rank
RNA
RXST
RNA vs. RXST - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Avidity Biosciences, Inc. (RNA) and RxSight, Inc. (RXST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
RNA vs. RXST - Dividend Comparison
Neither RNA nor RXST has paid dividends to shareholders.
Drawdowns
RNA vs. RXST - Drawdown Comparison
The maximum RNA drawdown since its inception was -86.45%, which is greater than RXST's maximum drawdown of -53.63%. Use the drawdown chart below to compare losses from any high point for RNA and RXST. For additional features, visit the drawdowns tool.
Volatility
RNA vs. RXST - Volatility Comparison
Avidity Biosciences, Inc. (RNA) has a higher volatility of 14.12% compared to RxSight, Inc. (RXST) at 11.15%. This indicates that RNA's price experiences larger fluctuations and is considered to be riskier than RXST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
RNA vs. RXST - Financials Comparison
This section allows you to compare key financial metrics between Avidity Biosciences, Inc. and RxSight, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities